Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging. The GE SPECT Multicenter Adenosine Study Group.

[1]  P. V. Streek,et al.  Thallium-201 scintigraphy after intravenous infusion of adenosine compared with exercise thallium testing in the diagnosis of coronary artery disease. , 1991, Journal of the American College of Cardiology.

[2]  J. Heo,et al.  Single photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography. , 1990, Journal of the American College of Cardiology.

[3]  R. Wilson,et al.  Effects of adenosine on human coronary arterial circulation. , 1990, Circulation.

[4]  M. Verani,et al.  Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. , 1990, Circulation.

[5]  J. O’Meara,et al.  Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. , 1990, The American journal of cardiology.

[6]  A. Hutter,et al.  Prognostic utility of predischarge dipyridamole-thallium imaging compared to predischarge submaximal exercise electrocardiography and maximal exercise thallium imaging after uncomplicated acute myocardial infarction. , 1989, The American journal of cardiology.

[7]  N. Gupta,et al.  Myocardial uptake and clearance of T1-201 in healthy subjects: comparison of adenosine-induced hyperemia and exercise stress. , 1989, Radiology.

[8]  G. Beller,et al.  Quantitative comparison of thallium-201 scintigraphy after exercise and dipyridamole in coronary artery disease. , 1989, The American journal of cardiology.

[9]  R. Berne,et al.  The cardiac effects of adenosine. , 1989, Progress in cardiovascular diseases.

[10]  M. Marcus,et al.  Coronary dilation with standard dose dipyridamole and dipyridamole combined with handgrip. , 1989, Circulation.

[11]  M. Verani,et al.  Quantitative thallium-201 single photon emission computed tomography after oral dipyridamole for assessing the presence, anatomic location and severity of coronary artery disease. , 1988, Journal of the American College of Cardiology.

[12]  B. Chaitman,et al.  Safety and diagnostic accuracy of dipyridamole-thallium imaging in the elderly. , 1988, Journal of the American College of Cardiology.

[13]  P. Barnes,et al.  Circulatory and respiratory effects of infused adenosine in conscious man. , 1987, British journal of clinical pharmacology.

[14]  B. Beermann,et al.  Adenosine-provoked angina pectoris-like pain--time characteristics, influence of autonomic blockade and naloxone. , 1987, European heart journal.

[15]  P. Barnes,et al.  Cardiovascular effects of infused adenosine in man: potentiation by dipyridamole. , 1987, Acta physiologica Scandinavica.

[16]  S. Homma,et al.  Safety of intravenous dipyridamole for stress testing with thallium imaging. , 1987, The American journal of cardiology.

[17]  K. Gould,et al.  Thallium-201 myocardial imaging during coronary vasodilation induced by oral dipyridamole. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  D. C. Brewster,et al.  Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. , 1985, The New England journal of medicine.

[19]  R. Okada,et al.  Thallium-201 myocardial perfusion imaging without exercise. Rest and dipyridamole studies. , 1984, Chest.

[20]  J. Leppo,et al.  Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. , 1984, The New England journal of medicine.

[21]  R. Klabunde.  Dipyridamole inhibition of adenosine metabolism in human blood. , 1983, European journal of pharmacology.

[22]  R. Dudczak,et al.  Thallium-201 imaging after dipyridamole in patients with coronary multivessel disease. , 1983, Cardiology.

[23]  R. Berne,et al.  Extracellular Action of Adenosine and the Antagonism by Aminophylline on the Atrioventricular Conduction of Isolated Perfused Guinea Pig and Rat Hearts , 1982, Circulation research.

[24]  G M Pohost,et al.  Serial Thallium‐201 Myocardial Imaging After Dipyridamole Infusion: Diagnostic Utility in Detecting Coronary Stenoses and Relationship to Regional Wall Motion , 1982, Circulation.

[25]  S. M. Collins,et al.  Tomographic Thallium‐201 Myocardial Perfusion Scintigrams After Maximal Coronary Artery Vasodilation with Intravenous Dipyridamole: Comparison of Qualitative and Quantitative Approaches , 1982, Circulation.

[26]  B. G. Brown,et al.  Noninvasive detection and localization of coronary stenoses in patients: comparison of resting dipyridamole and exercise thallium-201 myocardial perfusion imaging. , 1982, American heart journal.

[27]  E. Hoffman,et al.  Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography. , 1982, The American journal of cardiology.

[28]  Y. Raoul.  Physiological and Regulatory Functions of Adenosine and Adeine Nucleotides , 1980 .

[29]  G. Diamond,et al.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. , 1979, The New England journal of medicine.

[30]  E. Hoffman,et al.  Noninvasive assessment of coronary stenoses with myocardial perfusion imaging during pharmacologic coronary vasodilatation. V. Detection of 47 percent diameter coronary stenosis with intravenous nitrogen-13 ammonia and emission-computed tomography in intact dogs. , 1978, The American journal of cardiology.

[31]  J. Ritchie,et al.  Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial. , 1978, The American journal of cardiology.

[32]  R. Westcott,et al.  Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. II. Clinical methodology and feasibility. , 1978, The American journal of cardiology.